BTAI

BioXcel Therapeutics, Inc.

3.09 USD
+0.02 (+0.65%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

BioXcel Therapeutics, Inc. stock is down -6.65% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 83.33% of the previous 5 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 5 PUTs, 5 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Feb 19:45 16 Feb, 2024 2.50 PUT 1000 1345
12 Feb 20:58 16 Feb, 2024 1.50 CALL 1482 8414
14 Feb 17:36 17 May, 2024 3.00 CALL 402 140
14 Feb 18:31 15 Mar, 2024 3.50 CALL 4565 269
15 Feb 20:19 16 Feb, 2024 12.50 PUT 53 434
15 Feb 20:20 16 Feb, 2024 12.50 PUT 147 434
15 Feb 20:52 15 Mar, 2024 3.50 CALL 4987 5824
16 Feb 15:13 16 Feb, 2024 5.00 PUT 200 1058
16 Feb 15:13 16 Feb, 2024 5.00 PUT 200 1058
20 Feb 14:41 15 Mar, 2024 3.50 CALL 2499 15465

About BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. uses artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology in the United States. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.